(Reuters) – U.S. Vice President Joe Biden said on Monday the “moonshot” initiative he leads aimed at finding cures for cancer was “the only bipartisan thing left in America” and called for more collaboration among researchers, doctors and government agencies to advance the cause. Biden was speaking at the American Society of Clinical Oncology meeting […]
Oncology
Philips and Yale expand research deal
Royal Philips (NYSE:PHG) said today it expanded its master research agreement with Yale School of Medicine to include a new research program looking to develop innovations in interventional oncology. The multi-year cancer research program aims to explore new concepts in image-guided therapies, diagnostic imaging and informatics, Philips said, and will engage with multiple research groups […]
Pulse Biosciences pounds out $20m with IPO
Pulse Biosciences raised $20 million in an initial public offering this week after floating 5 million shares at $4 apiece, for a fully diluted valuation of $51 million. Burlingame, Calif.-based Pulse is developing “nano-pulse electro-signaling,” in which extremely short-duration pulsed electrical fields are directed at solid tumors. It’s designed to induce a type of programmed cell death […]
Siemens picks up German cancer diag company Neo New Oncology AG
Siemens (NYSE:SI) said yesterday it picked up German cancer genome diagnostic company Neo New Oncology AG for an undisclosed amount. The company said the purchase will give the company an “entry point” into next-generation-sequencing-based genomic testing as well as expanding its precision medicine and companion diagnostics. “Siemens Healthineers’ mission is to be the enabler of healthcare providers worldwide, […]
Sensus Healthcare scales back planned IPO
Sensus Healthcare last week said it plans to scale back its planned initial public offering, after tabling the flotation earlier this year. Boca Raton, Fla.-based Sensus makes the SRT-100 and SRT-100 Vision photon X-ray low-energy superficial radiotherapy systems for treating non-melanoma skin cancers, including basal cell and squamous cell carcinomas. The company said March 9 that it planned […]
FDA approves Biofrontera’s drug-device combo for sun-induced skin cancer
Biofrontera (ETR:B8F) shares are up today after the said it won pre-market approval from the FDA for its drug-device combination treatment for a type of sun-induced skin cancer. Leverkusen, Germany-based Biofrontera said the approval covers its Ameluz drug and BF-RhodoLED medical device for what it calls “photodynamic therapy” to treat mild to moderate actinic keratosis of the face […]
Median Technologies expands U.S. footprint
France’s Median Technologies (EPA:ALMDT) is consolidating and expanding in Massachusetts, with a new Woburn facility set to open next week. The medical imaging software maker and developer said the site will consolidate its existing operations in the Boston area, but also be big enough to handle an “ambitious U.S. recruitment plan.” A company spokesperson told MassDevice.com that the facility’s “exact […]
BTG puts up $110m for Galil Medical
BTG (LON:BTG) said it agreed to put a total of $110 million on the table for Galil Medical and its line of cryoablation devices for treating cancer. The deal calls for London-based BTG to pay $84.5 million (£58.3 million) in up-front cash and another $25.5 million (£17.6 million) in regulatory and commercial milestones, which are […]
FDA grants IDE to NovoCure for phase II Optune trial
NovoCure (NSDQ:NVCR) said today that Radiation Therapy Oncology Group Foundation won FDA investigational device exemption to conduct a Phase II pilot test of NovoCure’s Optune in conjunction with bevacizumab to treat bevacizumab-refractory recurrent glioblastoma. The Optune is a mobile device that delivers low-intensity, intermediate frequency, alternating electric fields, referred to as “tumor treating fields” to inhibit […]
Uganda’s only cancer treatment machine breaks, patients left waiting
(Reuters) – Thousands of cancer patients in Uganda will be left untreated for months after the nation’s only radiotherapy machine broke down, triggering public criticism about underfunding in the health system weeks after the president’s re-election. The device, bought in 1995 and sited at the main Mulago referral hospital, stopped working early in April, Christine […]
Varian backs Phase III non-small cell lung cancer trial
Varian Medical (NYSE:VAR) said today it is supporting a Phase III clinical trial set to compare outcomes of radiosurgery against surgical resection for treating early-stage, high-risk operable non-small cell lung cancer. The randomized “Stablemates Trial” will test the hypothesis that 3-year overall survival in high risk operable patients with Stage I NSCLC is equivalent or greater in […]